Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
2021 · The Lancet · 286 citations
https://doi.org/10.1016/s0140-6736(21)00845-x